In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole/Colistin Combination Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates

被引：12
|
作者：
Su, Jiachun [1 ,2 ]
Li, Dan [1 ,2 ]
Guo, Qinglan [1 ,2 ]
Guo, Yan [1 ,2 ]
Zheng, Yonggui [1 ,2 ]
Xu, Xiaogang [1 ,2 ,3 ]
机构：
[1] Fudan Univ, Huashan Hosp, Inst Antibiot, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China
[2] Natl Hlth & Family Planning Commiss, Key Lab Clin Pharmacol Antibiot, Shanghai, Peoples R China
[3] Fudan Univ, Huashan Hosp, Natl Clin Res Ctr Aging & Med, Shanghai, Peoples R China
来源：
MICROBIAL DRUG RESISTANCE | 2019年 / 25卷 / 02期
关键词：
carbapenem-resistant Klebsiella pneumoniae; trimethoprim-sulfamethoxazole; colistin; bactericidal activity; COLISTIN; THERAPY;
D O I：
10.1089/mdr.2018.0085
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Carbapenem-resistant Klebsiella pneumoniae (CRKP) has emerged as a formidable health challenge in recent years owing to the shortage of effective antibiotics. Colistin is the last and sometimes the only therapeutic option for CRKP infections. Unfortunately, resistance to colistin monotherapy is likely to develop. CRKP in China reportedly exhibit low rates of resistance to trimethoprim-sulfamethoxazole. The aim of this study was to evaluate the in vitro efficacy of trimethoprim-sulfamethoxazole in combination with colistin against four CRKP clinical isolates. The trimethoprim-sulfamethoxazole/colistin combination rapidly killed all four of the tested isolates after 2 h up to 24 h. Trimethoprim-sulfamethoxazole is one of the few remaining antimicrobials with some activity against CRKP. In particular, combined with colistin, trimethoprim-sulfamethoxazole might be promising for the treatment of CRKP infections.
引用
收藏
页码：152 / 156
页数：5
相关论文
共 50 条
  • [41] Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
    Gomez-Simmonds, A.
    Nelson, B.
    Eiras, D. P.
    Loo, A.
    Jenkins, S. G.
    Whittier, S.
    Calfee, D. P.
    Satlin, M. J.
    Kubin, C. J.
    Furuya, E. Y.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (06) : 3601 - 3607
  • [42] Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
    Ayerbe-Algaba, Rafael
    Luisa Gil-Marques, Maria
    Enrique Jimenez-Mejias, Manuel
    Sanchez-Encinales, Viviana
    Parra-Millan, Raquel
    Eugenia Pachon-Ibanez, Maria
    Pachon, Jeronimo
    Smani, Younes
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2018, 8
  • [43] In Vitro Evaluation of Synergy in Carbapenem-resistant Klebsiella pneumoniae Strains with Antibiotic Combinations of Meropenem, Fosfomycin, Colistin, and Tigecycline
    KandemIr, Ozlem
    Oksuz, Zehra
    Delialioglu, Nuran
    Aslan, Dogan Can
    SerIn, Mehmet Sami
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2021, 10
  • [44] Clinical Characteristics and Molecular Insights of Carbapenem-Resistant Klebsiella pneumoniae Isolates from Patients in Intensive Care Units
    Zhou, Yun
    Mu, Yinyu
    SURGICAL INFECTIONS, 2024, 25 (08) : 606 - 611
  • [45] Risk Factors for Subsequential Carbapenem-Resistant Klebsiella pneumoniae Clinical Infection Among Rectal Carriers with Carbapenem-Resistant Klebsiella pneumoniae
    Chen, Xia
    Liu, Qingnuan
    Liu, Wen-en
    Yan, Qun
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 1299 - 1305
  • [46] Synergistic activity of colistin with azidothymidine against colistin-resistant Klebsiella pneumoniae clinical isolates collected from inpatients in Greek hospitals
    Falagas, Matthew E.
    Voulgaris, Georgios L.
    Tryfinopoulou, Kyriaki
    Giakkoupi, Panagiota
    Kyriakidou, Margarita
    Vatopoulos, Alkiviadis
    Coates, Anthony
    Hu, Yanmin
    Tsiplakou, S.
    Papaioannou, V
    Trikka-Graphakos, E.
    Charalampakis, N.
    Sereti, C.
    Vogiatzakis, E.
    Moraiti, H.
    Xanthaki, A.
    Toutouza, M.
    Fountoulis, K.
    Perivolioti, E.
    Kraniotaki, H.
    Bournia, M.
    Vourli, S.
    Peteinaki, E.
    Makri, A.
    Daskalaki, M.
    Staikou, E.
    Platsouka, E.
    Spiliopoulou, I
    Christofidou, M.
    Tryfinopoulou, K.
    Giakkoupi, P.
    Vatopoulos, A.
    Vardakas, K.
    Voulgaris, G.
    Kyriakidou, M.
    Falagas, M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 53 (06) : 855 - 858
  • [47] Ri sk factors and mechanisms of in vivo emergence of colistin resistance in carbapenem-resistant Klebsiella pneumoniae
    Huang, Po-Han
    Cheng, Yi-Hsiang
    Chen, Wen-Yin
    Juan, Chih-Han
    Chou, Sheng-Hua
    Wang, Jin-Town
    Chuang, Chien
    Wang, Fu-Der
    Lin, Yi-Tsung
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 57 (06)
  • [48] In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii
    Abdul-Mutakabbir, Jacinda C.
    Yim, Juwon
    Nguyen, Logan
    Maassen, Philip T.
    Stamper, Kyle
    Shiekh, Zain
    Kebriaei, Razieh
    Shields, Ryan K.
    Castanheira, Mariana
    Kaye, Keith S.
    Rybak, Michael J.
    ANTIBIOTICS-BASEL, 2021, 10 (07):
  • [49] In vitro and in vivo Effect of Antimicrobial Agent Combinations Against Carbapenem-Resistant Klebsiella pneumoniae with Different Resistance Mechanisms in China
    Liu, Enbo
    Jia, Peiyao
    Li, Xue
    Zhou, Menglan
    Kudinha, Timothy
    Wu, Chuncai
    Xu, Yingchun
    Yang, Qiwen
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 917 - 928
  • [50] Investigation of carbapenemase and mcr-1 genes in carbapenem-resistant Klebsiella pneumoniae isolates
    Arabaci, Cigdem
    Dal, Tuba
    Basyigit, Tugcan
    Genisel, Neslihan
    Durmaz, Riza
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2019, 13 (06): : 504 - 509
12345